Fulgent Genetics Inc
NASDAQ:FLGT

Watchlist Manager
Fulgent Genetics Inc Logo
Fulgent Genetics Inc
NASDAQ:FLGT
Watchlist
Price: 20.06 USD -0.2% Market Closed
Market Cap: 610.6m USD

Wall Street
Price Targets

FLGT Price Targets Summary
Fulgent Genetics Inc

Wall Street analysts forecast FLGT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FLGT is 23.12 USD with a low forecast of 20.2 USD and a high forecast of 26.25 USD.

Lowest
Price Target
20.2 USD
1% Upside
Average
Price Target
23.12 USD
15% Upside
Highest
Price Target
26.25 USD
31% Upside
Fulgent Genetics Inc Competitors:
Price Targets
286A
EUCALIA Inc
46% Upside
LFST
Lifestance Health Group Inc
86% Upside
DGX
Quest Diagnostics Inc
6% Upside
LH
Laboratory Corporation of America Holdings
8% Upside
METROPOLIS
Metropolis Healthcare Ltd
10% Upside
CSTL
Castle Biosciences Inc
80% Upside
INNV
InnovAge Holding Corp
30% Upside
HI
Health Italia SpA
31% Upside

Revenue
Forecast

Revenue Estimate
Fulgent Genetics Inc

For the last 8 years the compound annual growth rate for Fulgent Genetics Inc's revenue is 41%. The projected CAGR for the next 3 years is 11%.

41%
Past Growth
11%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Fulgent Genetics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
23%
Average Beat

Net Income
Forecast

Net Income Estimate
Fulgent Genetics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
10%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is FLGT's stock price target?
Price Target
23.12 USD

According to Wall Street analysts, the average 1-year price target for FLGT is 23.12 USD with a low forecast of 20.2 USD and a high forecast of 26.25 USD.

What is Fulgent Genetics Inc's Revenue forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for Fulgent Genetics Inc's revenue is 41%. The projected CAGR for the next 3 years is 11%.

Back to Top